Logos Global Management LP Kymera Therapeutics, Inc. Transaction History

Logos Global Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$35.3 - $64.68 $7.06 Million - $12.9 Million	-200,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $9.98 Million - $13.1 Million	200,000 New	200,000 $12.7 Million
Q2 2021 Aug 16, 2021	SELL	$31.08 - $51.95 $8.11 Million - $13.6 Million	-260,920 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$35.64 - $85.46 $5.35 Million - $12.8 Million	150,000 Added 135.23%	260,920 $10.1 Million
Q4 2020 Feb 16, 2021	SELL	$28.07 - $87.83 $5.33 Million - $16.7 Million	-190,000 Reduced 63.14%	110,920 $6.88 Million
Q3 2020 Nov 16, 2020	BUY	$26.1 - $33.28 $7.85 Million - $10 Million	300,920 New	300,920 $9.72 Million

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.61B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.